Trademark: 97525470
Word
EXSTOBIO
Status
Pending
Status Code
688
Status Date
Tuesday, December 26, 2023
Serial Number
97525470
Mark Type
4000
Filing Date
Friday, July 29, 2022
Published for Opposition
Tuesday, October 31, 2023

Trademark Owner History
EXSTOBIO, INC. - Owner At Publication

Classifications
9 Downloadable computer software for providing counseling and digital therapeutics that utilize digital health technologies to treat and manage medical or psychological conditions; Downloadable computer application software, namely, software for processing electronic health records; Downloadable computer application software, namely, software for integrating risk evaluation information, mitigation strategies, and digital therapeutics into electronic health records; Downloadable software in the fields of healthcare, medicine and wellness for use in providing patient communication, care coordination and care management, chronic disease management, and engagement between health care providers and patients; Downloadable mobile application featuring technology that enables care providers and users to enter, access, and generate health and medical information and reports; Computer software, namely, downloadable software and mobile application software for remote monitoring of patients, the collection and transfer of healthcare data, facilitating communications and engagement among and between healthcare professionals, patients, vendors and suppliers of healthcare products and pharmaceuticals and to provide healthcare counseling and social support services to patients; Downloadable computer software, namely, downloadable software and mobile application software for connecting to, with and through smart devices and smart appliances, for the purposes of collecting data and health information for patient monitoring and communications purposes from and through such smart devices and smart appliances
45 Patient and family health care coordination services for use in case management, namely, providing health care advisory and management services for coordinating legal, medical, physical, social, personal care and psychological services
44 Medical services; Medical clinical services; Health counseling; Health care and wellness services, namely, medication tracking, patient education, and patient-centric health coaching and counseling; Pharmaceutical advice; Telemedicine services; Medical services, namely, providing medical advice in the nature of medicinal cannabidiol (CBD) recommendations and other product recommendations for medical treatment purposes and related ongoing medical care to patients; health care services, namely, providing remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Providing medical information in the field of therapeutic botanical substances; Providing health information in the field of cannabidiols, and regarding indications and effects of particular cannabis strains; Medical consultation services, namely, assessing patients for eligibility requirements for the use of cannabidiols; Providing medical testing of fitness for diagnostic purposes and medical consultations to individuals to help them make health, wellness, and nutritional changes to improve health
42 Medical research; Scientific research; Science and Technology Services, namely, technical consultation and scientific research in the field of cannabinoid-based medicines and pharmaceuticals; Development of precision cannabinoid therapeutics through digital therapeutics, medical research, scientific research, and expert consultation; Biological research; Compiling data for research purposes in the field of medical science and medical consultancy; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements for pain treatments, sleep treatments, and epilepsy treatments; Research and development of technology in the field of the prescription of therapeutic exercise programs; Research in the field of pharmaceutical studies; Platform as a service (PAAS) featuring computer software platforms for the development, deployment, and operation of patient-directed software for tracking prescription use and personal medical data in the field of Digital Therapeutics and treatment support; Software as a service (SaaS) and Platform as a service (PAAS) for targeting, monitoring, intervening, and managing human health conditions, behaviors, and disease, and treatments related thereto; Providing temporary use of online non-downloadable computer software for counseling and providing digital therapeutics that utilize digital and online health technologies to treat and manage medical or psychological conditions; Software as a service (SaaS) services featuring software for creating, accessing and editing electronic health records; Providing temporary use of non-downloadable computer application software, namely, software for integrating risk evaluation data, mitigation strategies, and digital therapeutics data into electronic health records; Providing interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing, namely, disease, treatment, trial, outcome and molecular diagnostic test results for decision support; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Software as a service (SAAS) services featuring software for integrating and analyzing patient health data for predictive analysis of health risks and health events; Software as a service (SAAS) featuring software in the fields of healthcare, medicine and wellness for the purpose of providing an integrated health information management system using machine learning and artificial intelligence, namely, software for providing patients and health care providers access to patient information and data, and for providing patients access to personalized information relevant to patient health and wellbeing; Providing temporary use of online non- downloadable interactive web-based software application featuring technology that enables care providers and users to enter, access, and generate health and medical information and reports; Software as a service (SaaS) services featuring non-downloadable software for remote monitoring of patients, the collection and transfer of healthcare data, facilitating communications and engagement among and between healthcare professionals, patients, vendors and suppliers of healthcare products and pharmaceuticals, and to provide healthcare counseling and social support services to patients; Providing a website featuring medical research information related to cannabidiols

Trademark Events
Dec 26, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 30, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 30, 2023
Teas Change Of Correspondence Received
Nov 30, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 30, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 31, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 31, 2023
Published For Opposition
Oct 11, 2023
Notification Of Notice Of Publication E-Mailed
Sep 21, 2023
Approved For Pub - Principal Register
Sep 20, 2023
Teas/Email Correspondence Entered
Sep 19, 2023
Correspondence Received In Law Office
Sep 19, 2023
Teas Response To Office Action Received
Sep 20, 2023
Teas Change Of Correspondence Received
Sep 20, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 20, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 11, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Aug 11, 2023
Teas Change Of Correspondence Received
Aug 11, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 11, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 27, 2023
Application Extension Granted/Receipt Provided
Jun 27, 2023
Application Extension To Response Period - Received
Apr 6, 2023
Notification Of Non-Final Action E-Mailed
Apr 6, 2023
Non-Final Action E-Mailed
Apr 6, 2023
Non-Final Action Written
Apr 6, 2023
Previous Allowance Count Withdrawn
Jan 10, 2023
Withdrawn From Pub - Og Review Query
Dec 26, 2022
Approved For Pub - Principal Register
Dec 23, 2022
Teas/Email Correspondence Entered
Dec 22, 2022
Correspondence Received In Law Office
Dec 22, 2022
Teas Response To Office Action Received
Sep 9, 2022
Notification Of Non-Final Action E-Mailed
Sep 9, 2022
Non-Final Action E-Mailed
Sep 9, 2022
Non-Final Action Written
Aug 29, 2022
Teas Change Of Correspondence Received
Aug 29, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Aug 29, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 29, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 20, 2022
Assigned To Examiner
Aug 18, 2022
New Application Office Supplied Data Entered
Aug 2, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24